Difference between revisions of "Proton pump inhibitor effect"

From Libre Pathology
Jump to navigation Jump to search
 
(One intermediate revision by one other user not shown)
Line 33: Line 33:


==Microscopic==
==Microscopic==
Features:<ref>{{Cite journal  | last1 = Driman | first1 = DK. | last2 = Wright | first2 = C. | last3 = Tougas | first3 = G. | last4 = Riddell | first4 = RH. | title = Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. | journal = Dig Dis Sci | volume = 41 | issue = 10 | pages = 2039-47 | month = Oct | year = 1996 | doi =  | PMID = 8888719 }}</ref>
Features:<ref name=pmid8888719>{{Cite journal  | last1 = Driman | first1 = DK. | last2 = Wright | first2 = C. | last3 = Tougas | first3 = G. | last4 = Riddell | first4 = RH. | title = Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. | journal = Dig Dis Sci | volume = 41 | issue = 10 | pages = 2039-47 | month = Oct | year = 1996 | doi =  | PMID = 8888719 }}</ref><ref>{{Pathologyoutlines| topic/stomachPPI}}</ref>
*Parietal cell enlargement - '''key feature'''.
*Parietal cell enlargement - '''key feature'''.
**Parietal cells typically bulge into the lumen.
**Parietal cells typically bulge into the lumen.
*G cell and enterochromaffin cell-like hyperplasia.
**Compensatory change due to increased pH in gastric lumen.
*Multiple fundic gland polyps (with PPI use over several months).
**Polyps may regress after PPI is stopped.


===Images===
===Images===

Latest revision as of 18:36, 2 March 2020

Proton pump inhibitor effect, abbreviated PPI effect, is a change seen in the parietal cells of the stomach due to a drug in the proton pump inhibitor class.

Stomach with PPI effect. H&E stain.

Formally, it is stomach with proton pump inhibitor effect.

General

Some proton pump inhibitors

Generic name Brand name(s)
Omeprazole LOSEC
Dexlansoprazole DEXILANT
Lansoprazole PREVACID
Esomeprazole NEXIUM
Pantoprazole PANTOLOC
Rabeprazole PARIET

Microscopic

Features:[1][2]

  • Parietal cell enlargement - key feature.
    • Parietal cells typically bulge into the lumen.
  • G cell and enterochromaffin cell-like hyperplasia.
    • Compensatory change due to increased pH in gastric lumen.
  • Multiple fundic gland polyps (with PPI use over several months).
    • Polyps may regress after PPI is stopped.

Images

www:

Sign out

  • Usually not reported.

See also

References

  1. Driman, DK.; Wright, C.; Tougas, G.; Riddell, RH. (Oct 1996). "Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.". Dig Dis Sci 41 (10): 2039-47. PMID 8888719.
  2. topic/stomachPPI.html topic/stomachPPI